Change of Party Committee of Pharmaceutical Company
Release time:
2020-07-22
Pharmaceutical Company Party Committee Change
News 10# July 10 Afternoon, Jianfeng Pharmaceutical Company held a Party Member Congress. Representatives of 50 Party Members from all subordinate units of the Pharmaceutical Company attended the meeting and elected members of the new Party Committee. Jin Huazhong, secretary of the party Committee of
Pharmaceutical Company, made a work report on behalf of the previous party Committee. He summarized the achievements of the party committee of the pharmaceutical company in the past five years from the aspects of strengthening party organization building, system building, team building, party style building, promoting enterprise development, and enhancing corporate brand influence. In the past five years, under the conditions of strict management of the pharmaceutical industry, continuous deepening of the new medical reform, frequent industry policies, and fierce competition, the party committee of the pharmaceutical company has closely focused on the central work of economic construction, strengthened the leadership of party building, and played the role of the party organization as a battle fortress and all party members. The vanguard and exemplary role of the company has achieved good economic and social benefits. The Party Committee of the Pharmaceutical Company is also organizing all Party members to strengthen theoretical study and improve their political accomplishment. To carry out various forms of "Theme " education activities to temper the party spirit of party members; To care about the lives of employees and enhance the cohesion of enterprises; The Party Working Group has done a lot of work in co-management and building a harmonious enterprise, and achieved good results. The report also puts forward suggestions on the work of the new Party committee from the aspects of strengthening theoretical study, carrying out "Do not forget your initiative mind, keeping in mind the mission " theme education, giving full play to the political core role of the Party committee, strengthening the construction of talent team, and strengthening the cooperation of the Party working group.
After voting by Party members' representatives and differential election, Huang Jinlong, Jin Huazhong and Shen Quan were elected as members of the new Party committee. The first meeting of the new party committee members held subsequently elected Jinhua as party secretary. Qin Xuping, member of the Party Committee of
Group Company and chairman of the trade union, attended the meeting on behalf of the Party Committee of the Group. In his speech, he asked the members of the new Party Committee to fully understand the importance of doing a good job in Party building in the new era. Carefully organize and carry out the theme education of "Do not forget your initiative mind, remember mission " ; Closely around the work, give full play to the political leading role of the party organization; strengthen theoretical study, continuously improve the political and theoretical quality of party members, and implement the learning party organization; innovate work ideas and continuously expand new areas of party building work. Huang Jinlong, member of the Party committee and deputy general manager of the group company, member of the Party committee and general manager of the pharmaceutical company, said in his concluding speech that the new party committee will, under the leadership of the group party committee, conscientiously study the relevant spirit of the central and higher levels, and carry out all kinds of work in the light of the actual situation of the enterprise. At the same time, he also put forward the hope of 6
"Centennial Peak " . After the meeting, the party Committee of the pharmaceutical company also organized representatives of party members to watch the movie "me and my motherland" dedicated to the birthday of new China 70
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page